{"meta":{"query_hash":"7a3a24110d24","filters":{"venue":"Therapeutic Advances in Drug Safety"},"cohort_total":33,"direct_labels_cover":0,"predictions_cover":33,"exported":33,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7a3a24110d24","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Drug+Safety"},"results":[{"id":"W1951433376","doi":"10.1177/2042098615588084","title":"Risk of intracranial hypertension with intrauterine levonorgestrel","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Levonorgestrel; Gestodene; Odds ratio; Drospirenone; Confidence interval; Population; Obstetrics; Gynecology; Internal medicine; Family planning","score_opus":0.017540775232581175,"score_gpt":0.26960085121288196,"score_spread":0.2520600759803008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1951433376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832571,0.008056807,0.00484169,0.00017392241,0.000023823904,0.00004707624,0.001568092,0.00006399432,0.0019674173],"genre_scores_gemma":[0.99532276,0.0016355912,0.0021922183,0.000048181813,0.000029086475,0.000020294116,0.00050519704,0.0000070512833,0.00023965792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982014,0.00057175197,0.00020728685,0.00033855,0.0006262679,0.000054775683],"domain_scores_gemma":[0.9931284,0.0020429126,0.003950713,0.00036965177,0.00040455532,0.000103793274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001844386,0.0003354579,0.00025284712,0.0010514976,0.00009469341,0.0005428018,0.00034998552,0.00025576245,0.001011588],"category_scores_gemma":[0.0069836383,0.00016070556,0.00068671216,0.0007797312,0.00023873351,0.00031031598,0.0003509506,0.0004025635,0.00015183324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051685463,0.000023420485,0.9794191,0.0001206466,0.00064849947,0.0002473202,0.000041823663,0.00041973803,0.00076599757,0.00010744827,0.0001191577,0.017569924],"study_design_scores_gemma":[0.000024367595,0.0006828931,0.9884637,0.000105899504,0.0005908741,0.0042890874,0.000059650843,0.002103829,0.0023172905,0.00015350075,0.0011889343,0.00001997969],"about_ca_topic_score_codex":0.0014774196,"about_ca_topic_score_gemma":0.0009271857,"teacher_disagreement_score":0.001844386,"about_ca_system_score_codex":0.00031443225,"about_ca_system_score_gemma":0.00029242758,"threshold_uncertainty_score":0.009754181},"labels":[],"label_agreement":null},{"id":"W2044764653","doi":"10.1177/2042098613492366","title":"Selective serotonin reuptake inhibitors and <i>torsade de pointes</i> : new concepts and new directions derived from a systematic review of case reports","year":2013,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Memorial University of Newfoundland","funders":"","keywords":"Citalopram; Medicine; QT interval; Sertraline; Fluoxetine; Serotonin reuptake inhibitor; Prolongation; Antidepressant; Food and drug administration; Long QT syndrome; Drug; Pharmacology; Culprit; Reuptake inhibitor; Intensive care medicine; Serotonin; Anesthesia; Psychiatry; Internal medicine","score_opus":0.01605437338666367,"score_gpt":0.32850619995567903,"score_spread":0.3124518265690154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044764653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004690886,0.99905854,0.000081235805,0.00017347849,0.00004255248,0.0000070843,0.000024115085,0.0000026322007,0.00014127677],"genre_scores_gemma":[0.008827877,0.9901715,0.00038506248,0.0002986462,0.00017020518,0.000015149822,0.000049299866,0.0000018226717,0.00008042262],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.998348,0.0003469664,0.0006997373,0.00017694711,0.00037339222,0.00005497743],"domain_scores_gemma":[0.99125075,0.00540336,0.0023246745,0.00018652019,0.0007577829,0.000076923956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021489062,0.00081667316,0.0018552787,0.006589085,0.00025138157,0.0010287537,0.0009803094,0.0010029739,0.0018258075],"category_scores_gemma":[0.008430905,0.00030545433,0.0013772807,0.006984756,0.00049613474,0.0021239927,0.00046772978,0.0005859804,0.00027982786],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019373962,0.000059807866,0.009371125,0.31006658,0.0026953947,0.0066130357,0.0005749423,0.0003600187,0.0015508225,0.0016403906,0.016477222,0.650397],"study_design_scores_gemma":[0.00018799207,0.00044518584,0.0545508,0.4780169,0.022307575,0.10519593,0.0022076066,0.000646389,0.0021100931,0.0048539755,0.3293054,0.00017213536],"about_ca_topic_score_codex":0.0014645869,"about_ca_topic_score_gemma":0.0036953539,"teacher_disagreement_score":0.006589085,"about_ca_system_score_codex":0.00067134114,"about_ca_system_score_gemma":0.0023716763,"threshold_uncertainty_score":0.011364639},"labels":[],"label_agreement":null},{"id":"W2099543072","doi":"10.1177/2042098612451267","title":"Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks?","year":2012,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Diabetes mellitus; Primary prevention; Intensive care medicine; Secondary prevention; Disease; Internal medicine; Endocrinology","score_opus":0.024539556583118998,"score_gpt":0.305003854526432,"score_spread":0.28046429794331296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099543072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009008136,0.99937767,0.000035821056,0.00015608277,0.00006556066,0.00000270896,0.000008460927,0.0000018763737,0.00026169597],"genre_scores_gemma":[0.00039271073,0.9992155,0.000099815996,0.000095381714,0.000057827274,0.0000031276784,0.000009878486,4.5898696e-7,0.00012528544],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997528,0.000053092917,0.00006136373,0.000031465934,0.000086386826,0.000014804392],"domain_scores_gemma":[0.9996648,0.00016811115,0.00006711072,0.0000075584567,0.00007697269,0.000015435568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006200239,0.00066811277,0.0017142433,0.0016919932,0.00022421448,0.0008072116,0.00063027407,0.0008949182,0.0027201963],"category_scores_gemma":[0.00091018266,0.00022753204,0.00069272687,0.0018280552,0.00028495066,0.0010418181,0.00038980856,0.0014072433,0.0012303588],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014181409,0.00008061565,0.00023116638,0.05181528,0.00031698137,0.00020566952,0.00008153878,0.00017752036,0.001563496,0.001962913,0.01564329,0.9277798],"study_design_scores_gemma":[0.00012170103,0.00032256194,0.003132412,0.027460825,0.0011117466,0.0030462395,0.0002106125,0.00020820703,0.0010236929,0.0033167936,0.96000344,0.00004189722],"about_ca_topic_score_codex":0.0007954953,"about_ca_topic_score_gemma":0.0018015021,"teacher_disagreement_score":0.0027201963,"about_ca_system_score_codex":0.00032621803,"about_ca_system_score_gemma":0.00081859087,"threshold_uncertainty_score":0.00910002},"labels":[],"label_agreement":null},{"id":"W2159872359","doi":"10.1177/2042098613505614","title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","year":2013,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pregabalin; Medicine; Neuropathic pain; Pain management; Intensive care medicine; Anesthesia","score_opus":0.11080718598801527,"score_gpt":0.44203784279271413,"score_spread":0.3312306568046989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159872359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000099548175,0.9986646,0.000056155488,0.0002368705,0.000101325786,0.0000034667812,0.000014665934,0.000004217638,0.00081920426],"genre_scores_gemma":[0.00048502942,0.9989858,0.0001137158,0.00012854194,0.000073882264,0.0000028037691,0.000014842182,8.6844045e-7,0.00019435353],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99970406,0.000044453787,0.00006808669,0.00004697607,0.000116068804,0.000020360694],"domain_scores_gemma":[0.99936515,0.0003068413,0.000116083465,0.000015854863,0.00016268484,0.000033435863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007019158,0.0007619294,0.0012878648,0.0023729457,0.000278547,0.000974786,0.000678089,0.00092434464,0.005257405],"category_scores_gemma":[0.0011234259,0.00024925722,0.000732259,0.0030160577,0.0004540317,0.001148407,0.00061834377,0.001597177,0.001790975],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075441894,0.000049334412,0.00016006822,0.03614937,0.00010392301,0.00020703384,0.00006364918,0.00015318512,0.00137237,0.0017479972,0.01388883,0.9460288],"study_design_scores_gemma":[0.000034882785,0.00014183608,0.0016300317,0.018861908,0.0004595296,0.0026261518,0.00014757525,0.000094211726,0.0009238709,0.0022399216,0.972809,0.000031050342],"about_ca_topic_score_codex":0.0011404695,"about_ca_topic_score_gemma":0.002695138,"teacher_disagreement_score":0.005257405,"about_ca_system_score_codex":0.0005931762,"about_ca_system_score_gemma":0.0015004112,"threshold_uncertainty_score":0.017587721},"labels":[],"label_agreement":null},{"id":"W2161475157","doi":"10.1177/2042098611424178","title":"Latest drug safety alerts from the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of South Australia; Norwegian Institute of Public Health; Institute for Clinical Evaluative Sciences; U.S. Department of Veterans Affairs","keywords":"Pharmacoepidemiology; Medicine; Drug; Pharmacovigilance; Drug reaction; Pharmacology; Medical emergency; Intensive care medicine","score_opus":0.0853446839540162,"score_gpt":0.4357289746764908,"score_spread":0.35038429072247457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161475157","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008259313,0.12277784,0.023024803,0.45357573,0.11913755,0.0019468867,0.013385033,0.0033723584,0.25452054],"genre_scores_gemma":[0.06849704,0.22645777,0.030712167,0.072826095,0.15900202,0.0014680347,0.04368327,0.0014332758,0.39592025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943699,0.0011552874,0.00052256254,0.00025523122,0.0033444944,0.00035244157],"domain_scores_gemma":[0.98163337,0.0026289402,0.002004081,0.00035741122,0.010478201,0.0028980132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00894038,0.0012523929,0.0013112681,0.0037034785,0.0008393287,0.0052150595,0.0011352911,0.0033919134,0.051501464],"category_scores_gemma":[0.018452667,0.0004806327,0.0010923129,0.0018164936,0.00038596883,0.0018842017,0.0017093502,0.0049060853,0.021892056],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015701063,0.000061805884,0.00089041266,0.00028155276,0.000038759215,0.00013632399,0.000031139007,0.00012660018,0.00056660076,0.0005011419,0.8660696,0.13113904],"study_design_scores_gemma":[0.00006961432,0.00012395428,0.0067775855,0.0006222285,0.000074963704,0.00040759414,0.00005474277,0.00041384384,0.0011011739,0.0009924265,0.9893126,0.00004926335],"about_ca_topic_score_codex":0.0021552313,"about_ca_topic_score_gemma":0.0049904315,"teacher_disagreement_score":0.051501464,"about_ca_system_score_codex":0.0016753195,"about_ca_system_score_gemma":0.0032962223,"threshold_uncertainty_score":0.17228955},"labels":[],"label_agreement":null},{"id":"W2168494345","doi":"10.1177/2042098611429985","title":"Does orlistat cause acute kidney injury?","year":2011,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute for Clinical Evaluative Sciences","keywords":"Orlistat; Medicine; Acute kidney injury; Intensive care medicine; Weight loss; Internal medicine; Obesity","score_opus":0.0337585266041335,"score_gpt":0.3994630283586332,"score_spread":0.3657045017544997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168494345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011546375,0.99869555,0.000049045986,0.00044458755,0.00015567499,0.0000025549998,0.000010011819,0.0000027758686,0.00052432745],"genre_scores_gemma":[0.0005424528,0.99864167,0.000050549115,0.00026500574,0.00019037961,0.0000027123606,0.000010883506,5.4052214e-7,0.00029577175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997737,0.000041986972,0.000044392105,0.000030020274,0.00009254907,0.000017370872],"domain_scores_gemma":[0.9997631,0.00010816108,0.00005786559,0.000007302443,0.00005013966,0.00001338621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048451367,0.0007052221,0.0017615645,0.00127766,0.00023267441,0.00090404606,0.0006143256,0.0011902982,0.002711347],"category_scores_gemma":[0.0007778106,0.00020671851,0.0005395452,0.0014145169,0.00040841947,0.0013279116,0.00047108476,0.0012214106,0.0015935844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015498168,0.00007154846,0.00040563307,0.029876122,0.00025491603,0.00041569633,0.00007694594,0.00016169272,0.001848915,0.002346525,0.025701206,0.93868583],"study_design_scores_gemma":[0.00008604121,0.00021660548,0.003368751,0.013178512,0.0005544058,0.0052084364,0.000183306,0.00012084157,0.0014358964,0.0042755017,0.9713387,0.00003304258],"about_ca_topic_score_codex":0.00082309544,"about_ca_topic_score_gemma":0.0017335981,"teacher_disagreement_score":0.002711347,"about_ca_system_score_codex":0.0003994023,"about_ca_system_score_gemma":0.00087757065,"threshold_uncertainty_score":0.009070396},"labels":[],"label_agreement":null},{"id":"W2475587874","doi":"10.1177/2042098616660947","title":"Citalopram and escitalopram: adverse cardiac outcomes in medically ill inpatients","year":2016,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Drug Safety","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"Escitalopram; Medicine; Citalopram; Adverse effect; Intensive care medicine; Emergency medicine; Anesthesia; Internal medicine; Pharmacology; Antidepressant","score_opus":0.004056710642449825,"score_gpt":0.2849074620933553,"score_spread":0.2808507514509055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475587874","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9425123,0.028203458,0.0001941695,0.010933165,0.00030078576,0.00008799643,0.0024191614,0.000029400857,0.015319688],"genre_scores_gemma":[0.98367345,0.010267144,0.00028856008,0.0029900116,0.0006504229,0.000042914857,0.0010799577,0.000006664463,0.0010008228],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942315,0.00009240102,0.000120125114,0.00005166645,0.00021989182,0.000092727816],"domain_scores_gemma":[0.99763584,0.00022808986,0.0014044178,0.00003088604,0.00031840845,0.0003823905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037891412,0.00015359373,0.00038347725,0.0004560654,0.00062432094,0.00051670254,0.0001726132,0.00054692535,0.0025757465],"category_scores_gemma":[0.003278455,0.00011356744,0.0005185402,0.0007223808,0.00014799136,0.00032564657,0.00052428566,0.0010971136,0.0002574113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006641443,0.00015676577,0.9396459,0.00043266884,0.00018822751,0.0015378755,0.00021977125,0.00007996846,0.0003130083,0.00020587341,0.006639322,0.04991642],"study_design_scores_gemma":[0.000035974255,0.00015572573,0.99370754,0.00036209272,0.00014866727,0.002316981,0.00028048444,0.00014445512,0.0000747737,0.00016680983,0.0025927932,0.00001356045],"about_ca_topic_score_codex":0.007830142,"about_ca_topic_score_gemma":0.01377655,"teacher_disagreement_score":0.007830142,"about_ca_system_score_codex":0.0008357781,"about_ca_system_score_gemma":0.0008801298,"threshold_uncertainty_score":0.01556915},"labels":[],"label_agreement":null},{"id":"W2534941481","doi":"10.1177/2042098616673990","title":"Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Rivaroxaban; Dabigatran; Atrial fibrillation; Apixaban; Stroke (engine); Warfarin; Intensive care medicine; Clinical trial; Guideline; Clinical Practice; Randomized controlled trial; Internal medicine; Physical therapy","score_opus":0.1279470371399663,"score_gpt":0.42488757964953555,"score_spread":0.29694054250956925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534941481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096423464,0.99856526,0.00009742897,0.00080449315,0.00017148473,0.0000074811996,0.000025477144,0.0000019587792,0.0002299199],"genre_scores_gemma":[0.001862186,0.9960353,0.00031407207,0.0010270657,0.0005926696,0.000023148605,0.000051613533,0.000001896972,0.00009209166],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9936985,0.0018821444,0.0023007002,0.0004681361,0.0015265942,0.0001239334],"domain_scores_gemma":[0.97133684,0.02254711,0.0036006083,0.00026913447,0.0020940544,0.00015226181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005632025,0.0010194372,0.0029908433,0.0030665055,0.00033339954,0.0027024932,0.001129351,0.0025122424,0.0033103738],"category_scores_gemma":[0.019329216,0.0004625114,0.0022817836,0.0025227389,0.0008493391,0.0026147845,0.0009336188,0.0027078062,0.0006431],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043378244,0.00010408166,0.000923403,0.2623844,0.002172417,0.00033075604,0.00026343804,0.0003800902,0.000983811,0.004307178,0.02367964,0.7040371],"study_design_scores_gemma":[0.00028306872,0.0009031923,0.006722292,0.3240159,0.014517103,0.005371598,0.00047203005,0.0004640775,0.0015232058,0.008929794,0.6366594,0.00013843065],"about_ca_topic_score_codex":0.001043134,"about_ca_topic_score_gemma":0.0015186411,"teacher_disagreement_score":0.005632025,"about_ca_system_score_codex":0.0011808949,"about_ca_system_score_gemma":0.003236057,"threshold_uncertainty_score":0.029785395},"labels":[],"label_agreement":null},{"id":"W2586356521","doi":"10.1177/2042098616689771","title":"Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events","year":2017,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council","keywords":"Concomitant; Apixaban; Medicine; Adverse effect; Odds ratio; Adverse drug reaction; Internal medicine; Emergency medicine; Drug; Warfarin; Pharmacology","score_opus":0.031873528298698946,"score_gpt":0.3541906558766836,"score_spread":0.32231712757798464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586356521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8939574,0.06824257,0.0034244496,0.0052541257,0.00020773614,0.0003138227,0.018290734,0.00011676479,0.0101924725],"genre_scores_gemma":[0.9796139,0.011870114,0.0016895541,0.00075408706,0.00023968826,0.00010714462,0.005308241,0.000014460468,0.0004028634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9815679,0.0051641315,0.0055379514,0.001667724,0.005621885,0.00044047966],"domain_scores_gemma":[0.84532076,0.04841159,0.09192482,0.0038059058,0.009221727,0.0013152194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011935073,0.00022104073,0.00038661715,0.0028833367,0.00037559058,0.0018884535,0.0005949978,0.00048112433,0.0033232362],"category_scores_gemma":[0.06466372,0.00023182783,0.0008785655,0.005447456,0.00071608427,0.0013760888,0.0009806027,0.0005430166,0.00038225055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035459365,0.0000398924,0.95548445,0.0018687975,0.00055923697,0.00019049666,0.0003296911,0.00019598496,0.00016825818,0.00029371178,0.0017691513,0.038745835],"study_design_scores_gemma":[0.000020952066,0.00010622188,0.9920081,0.0007220746,0.00018074481,0.0014723333,0.00029088106,0.0003179209,0.00021246432,0.00033004925,0.004320107,0.000018145476],"about_ca_topic_score_codex":0.016183417,"about_ca_topic_score_gemma":0.0118437745,"teacher_disagreement_score":0.016183417,"about_ca_system_score_codex":0.0011120081,"about_ca_system_score_gemma":0.0020695925,"threshold_uncertainty_score":0.06311941},"labels":[],"label_agreement":null},{"id":"W2610100066","doi":"10.1177/2042098617702615","title":"Risk factors for adverse drug reactions in pediatric inpatients: a systematic review","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Provincial Health Services Authority; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Observational study; MEDLINE; Medical prescription; Cohort study; Data extraction; Population; Risk factor; Pharmacoepidemiology; Incidence (geometry); Systematic review; Epidemiology; Cohort; Prospective cohort study; Pediatrics; Internal medicine; Environmental health; Pharmacology","score_opus":0.10653980338035274,"score_gpt":0.45913101452308125,"score_spread":0.3525912111427285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610100066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003305592,0.99545896,0.00013065181,0.00017054971,0.00006351511,0.00023176165,0.00046337015,0.000005404192,0.0001702538],"genre_scores_gemma":[0.05383708,0.9433296,0.0008838756,0.0005334693,0.00014144261,0.0006578254,0.00051508035,0.0000044165986,0.000097273565],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9920358,0.0023184852,0.003376593,0.0007166145,0.0013381679,0.0002144414],"domain_scores_gemma":[0.9680607,0.021857917,0.0075674746,0.0004896964,0.0017807777,0.0002434261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070545673,0.0011690296,0.0061748154,0.00644158,0.00042483784,0.0016228396,0.0014313421,0.0014316031,0.0027227378],"category_scores_gemma":[0.031376865,0.00085065525,0.008388882,0.006565696,0.0005236222,0.0012995265,0.0008390041,0.0008953916,0.00016342543],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029785815,0.000026459416,0.009053798,0.935636,0.028014794,0.00018911234,0.00015268702,0.00012579541,0.00010168859,0.00014263163,0.0010138965,0.025245255],"study_design_scores_gemma":[0.00040512424,0.00045416006,0.040469073,0.73133856,0.21026088,0.0011109576,0.00037892524,0.00020270697,0.00023767515,0.00029249856,0.014785839,0.000063631225],"about_ca_topic_score_codex":0.005767105,"about_ca_topic_score_gemma":0.014328738,"teacher_disagreement_score":0.0070545673,"about_ca_system_score_codex":0.0020157795,"about_ca_system_score_gemma":0.0060860394,"threshold_uncertainty_score":0.037308574},"labels":[],"label_agreement":null},{"id":"W2705232493","doi":"10.1177/2042098617709768","title":"Revised disproportionality analysis of Mirena and benign intracranial hypertension","year":2017,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Intensive care medicine; Internal medicine","score_opus":0.0213415122708033,"score_gpt":0.3203688792583498,"score_spread":0.2990273669875465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2705232493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89975286,0.009410372,0.023619086,0.0039583854,0.0010643593,0.0004896095,0.04358717,0.00033750266,0.017780686],"genre_scores_gemma":[0.9869522,0.0006886304,0.0031088418,0.0003882224,0.0003325326,0.00011418944,0.007549934,0.00006170306,0.0008038565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9862671,0.0061339536,0.002185055,0.0017866099,0.0025954149,0.0010319018],"domain_scores_gemma":[0.9711368,0.0110427765,0.006885681,0.005723694,0.004201408,0.0010096601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014148822,0.00065809634,0.0011642472,0.0047735414,0.0005857007,0.0018423419,0.0012675318,0.0005726773,0.0056159287],"category_scores_gemma":[0.045086306,0.00037289213,0.0048319064,0.0037105952,0.00047062253,0.0012213873,0.0026536095,0.0014879395,0.0007785099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024093853,0.000053038606,0.94789916,0.00037754973,0.006546759,0.00033849667,0.00017554538,0.0013190373,0.0007259907,0.0033547082,0.0070801727,0.029720075],"study_design_scores_gemma":[0.00017380719,0.0005196282,0.97158784,0.00024096656,0.0050780587,0.001535428,0.00040144517,0.0052359216,0.00089552224,0.0025967555,0.011665753,0.000068919144],"about_ca_topic_score_codex":0.006360677,"about_ca_topic_score_gemma":0.004927806,"teacher_disagreement_score":0.014148822,"about_ca_system_score_codex":0.0007884518,"about_ca_system_score_gemma":0.0016579429,"threshold_uncertainty_score":0.074827015},"labels":[],"label_agreement":null},{"id":"W2786833446","doi":"10.1177/2042098617751498","title":"Managing acute pain in patients who report lactose intolerance: the safety of an old excipient re-examined","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lactose intolerance; Medicine; Codeine; Lactose; Population; Intensive care medicine; Adverse effect; Excipient; Pharmacy; Anesthesia; Morphine; Pharmacology; Food science; Environmental health","score_opus":0.013765477836603781,"score_gpt":0.32945774833548575,"score_spread":0.315692270498882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786833446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21043213,0.49342987,0.016244726,0.20495477,0.0067245625,0.00036801767,0.000056184344,0.00030721794,0.06748238],"genre_scores_gemma":[0.6364682,0.277688,0.02314563,0.0454112,0.010161724,0.00019982569,0.000084334555,0.00006581507,0.0067753224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990363,0.00041174356,0.00013887131,0.000052111667,0.00026804575,0.00009288563],"domain_scores_gemma":[0.99805534,0.00085635553,0.00043726328,0.0000719178,0.00034365436,0.00023557583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001782222,0.00032466854,0.0006121198,0.0005789558,0.0008776029,0.001509389,0.0006861299,0.0024231074,0.0017046422],"category_scores_gemma":[0.008219452,0.00012584528,0.00055769,0.00043907482,0.0012268084,0.0016985298,0.0012606021,0.002200713,0.0006535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003911001,0.0004481612,0.0559643,0.0028724868,0.00015504989,0.07556878,0.0050937245,0.00046043584,0.0035477516,0.0035277044,0.025438294,0.8265323],"study_design_scores_gemma":[0.00035118838,0.0071184356,0.124140374,0.013627308,0.00048512823,0.48126468,0.03433031,0.0018643115,0.002684666,0.011783845,0.3221461,0.00020363794],"about_ca_topic_score_codex":0.00085378083,"about_ca_topic_score_gemma":0.0024342348,"teacher_disagreement_score":0.0024231074,"about_ca_system_score_codex":0.00058362266,"about_ca_system_score_gemma":0.001046021,"threshold_uncertainty_score":0.009425402},"labels":[],"label_agreement":null},{"id":"W2829531973","doi":"10.1177/2042098618795770","title":"Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Deprescribing; Nice; Context (archaeology); Polypharmacy; Guideline; Excellence; Pharmacist; Medication therapy management; Regimen; Family medicine; Multimorbidity; Intensive care medicine; Pharmacy; Chronic disease; Internal medicine","score_opus":0.10680681770426757,"score_gpt":0.45466308968180696,"score_spread":0.3478562719775394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2829531973","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13584661,0.032202013,0.0118166525,0.7804237,0.0018167045,0.001521248,0.0007109613,0.00012601964,0.03553609],"genre_scores_gemma":[0.7562041,0.030741712,0.13402873,0.0736675,0.0013049502,0.0016503969,0.0007548987,0.000051666197,0.0015960629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95851,0.028051447,0.004535165,0.0009808275,0.0069452794,0.000977369],"domain_scores_gemma":[0.8265156,0.08518457,0.03566963,0.0044446895,0.034042496,0.014142987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025178488,0.00035322065,0.0006995141,0.0018346265,0.0026713044,0.0041309185,0.0026127384,0.004558911,0.002617009],"category_scores_gemma":[0.19254224,0.00038397586,0.0010240966,0.0020496722,0.0028305412,0.003678902,0.0025466199,0.0038518636,0.00051498826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028863686,0.0013559344,0.22298032,0.010839859,0.0003009609,0.0040678303,0.052514266,0.0039310395,0.000765645,0.040354017,0.23357911,0.42902234],"study_design_scores_gemma":[0.00070410164,0.0018696787,0.23116565,0.08167736,0.0006021311,0.0071588666,0.11105072,0.013966997,0.00086245046,0.11333995,0.436936,0.0006660778],"about_ca_topic_score_codex":0.023540922,"about_ca_topic_score_gemma":0.060414944,"teacher_disagreement_score":0.025178488,"about_ca_system_score_codex":0.006427451,"about_ca_system_score_gemma":0.023620421,"threshold_uncertainty_score":0.1331582},"labels":[],"label_agreement":null},{"id":"W2891540702","doi":"10.1177/2042098618794165","title":"Strategies to promote public engagement around deprescribing","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Vancouver Coastal Health; Canadian Patient Safety Institute; University of British Columbia; Institut Universitaire de Gériatrie de Montréal","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Deprescribing; Polypharmacy; Medicine; Enabling; Public relations; Nursing; Psychiatry; Political science","score_opus":0.25095876490454566,"score_gpt":0.4807666275083062,"score_spread":0.22980786260376052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891540702","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12110547,0.0037954769,0.05034735,0.5640223,0.003668462,0.009393931,0.00029320232,0.001742978,0.24563086],"genre_scores_gemma":[0.77284586,0.00509766,0.07531639,0.08916005,0.00141377,0.0102611035,0.0005694931,0.0003193775,0.045016434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9614271,0.022563027,0.001027917,0.0017150006,0.006078628,0.007188336],"domain_scores_gemma":[0.9279145,0.025404666,0.005739494,0.003495584,0.011566013,0.0258797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042511925,0.0014460379,0.0006870889,0.003816415,0.016953373,0.009082608,0.004229679,0.0073351352,0.011837599],"category_scores_gemma":[0.051705196,0.00073780044,0.0015102085,0.0020167746,0.007705161,0.00847141,0.025478184,0.011450673,0.0021376915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023133155,0.0021107483,0.022000883,0.002158225,0.00011069461,0.0017470157,0.27129418,0.001495622,0.003881835,0.061797813,0.16862369,0.46454793],"study_design_scores_gemma":[0.0002454737,0.00053623645,0.01740441,0.002676479,0.00009909335,0.00040461426,0.14179127,0.0017581611,0.0016016379,0.03155538,0.8017475,0.00017967582],"about_ca_topic_score_codex":0.088474564,"about_ca_topic_score_gemma":0.13300128,"teacher_disagreement_score":0.088474564,"about_ca_system_score_codex":0.021461561,"about_ca_system_score_gemma":0.10593806,"threshold_uncertainty_score":0.22482723},"labels":[],"label_agreement":null},{"id":"W2897929033","doi":"10.1177/2042098618804490","title":"Deprescribing conversations: a closer look at prescriber–patient communication","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; University of Ottawa; University of Waterloo; Centre Integre de Sante et de Services Sociaux de Laval; Université de Montréal; Institut Universitaire de Gériatrie de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Deprescribing; Medicine; Conversation; Thematic analysis; Health care; Action (physics); Family medicine; Nursing; Qualitative research; Psychology; Polypharmacy; Internal medicine; Communication","score_opus":0.0979747242222918,"score_gpt":0.3990011828173144,"score_spread":0.3010264585950226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897929033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98140323,0.0035978158,0.0022575639,0.004254905,0.00010387037,0.000081913786,0.00019410018,0.000030182257,0.008076309],"genre_scores_gemma":[0.99489164,0.0018818739,0.0015208315,0.0007891979,0.00007792826,0.00006201528,0.00008887854,0.000024239233,0.0006632945],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9940838,0.004226489,0.00030437845,0.00028100357,0.0005869906,0.0005172771],"domain_scores_gemma":[0.9738609,0.022200778,0.001924547,0.0003191626,0.0011192426,0.0005752849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005881406,0.00028159987,0.0004708055,0.0023550394,0.0024802645,0.0037668434,0.0006610063,0.0014170368,0.0026282694],"category_scores_gemma":[0.014950626,0.00033085883,0.00038251575,0.001561434,0.0023548307,0.0053237067,0.0029453647,0.0017429455,0.00024099993],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016184279,0.000056610643,0.035801377,0.00069161766,0.00002754098,0.0012049573,0.9310973,0.00005618617,0.0028488627,0.000808485,0.00073932635,0.026505837],"study_design_scores_gemma":[0.000016078004,0.00022704357,0.15464902,0.0010226314,0.00004972985,0.003430197,0.8165452,0.0004005618,0.0018479817,0.0012845376,0.020477114,0.000049956114],"about_ca_topic_score_codex":0.003643573,"about_ca_topic_score_gemma":0.0054143877,"teacher_disagreement_score":0.005881406,"about_ca_system_score_codex":0.0021417162,"about_ca_system_score_gemma":0.0016967528,"threshold_uncertainty_score":0.031104207},"labels":[],"label_agreement":null},{"id":"W2910310106","doi":"10.1177/2042098618816562","title":"The impact of in hospital patient-education intervention on older people’s attitudes and intention to have their benzodiazepines deprescribed: a feasibility study","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Sleep and related disorders","field":"Psychology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Deprescribing; Intervention (counseling); Population; Interquartile range; Family medicine; Psychiatry; Polypharmacy; Internal medicine","score_opus":0.009310330328651025,"score_gpt":0.3451581186524846,"score_spread":0.33584778832383355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910310106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416107,0.000027160577,0.00015707416,0.00008523465,0.000018447461,0.0050493074,0.00004909045,0.000009345411,0.00044316825],"genre_scores_gemma":[0.98039925,0.00014232789,0.0030300813,0.00017021362,0.0000810312,0.015521512,0.00009924212,0.000003820158,0.00055255607],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99525696,0.0031765602,0.00031310797,0.00024780977,0.000336334,0.0006691438],"domain_scores_gemma":[0.993032,0.0034225895,0.0011534985,0.00038811564,0.0005635472,0.0014401596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069633042,0.00094156765,0.0007822727,0.00070106215,0.0011266586,0.0005862567,0.0007821259,0.0012753031,0.004321841],"category_scores_gemma":[0.008689333,0.00063628005,0.0010321091,0.00037786135,0.0010220313,0.0008663054,0.001180589,0.0012674666,0.00030507075],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10470518,0.7298626,0.040334914,0.0015009363,0.0002772697,0.0003695064,0.0072463374,0.0005069074,0.00495024,0.00022601016,0.00062984263,0.1093903],"study_design_scores_gemma":[0.05726191,0.8377765,0.09929151,0.00011016763,0.00022011189,0.00007003342,0.0019078751,0.00057309226,0.0016356813,0.00009166446,0.0010144633,0.00004701826],"about_ca_topic_score_codex":0.0017820675,"about_ca_topic_score_gemma":0.0027882417,"teacher_disagreement_score":0.0069633042,"about_ca_system_score_codex":0.0010668768,"about_ca_system_score_gemma":0.003615642,"threshold_uncertainty_score":0.036825895},"labels":[],"label_agreement":null},{"id":"W2929153482","doi":"10.1177/2042098619838796","title":"‘I think this medicine actually killed my wife’: patient and family perspectives on shared decision-making to optimize medications and safety","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Focus group; Thematic analysis; Conceptualization; Qualitative research; Medicine; Health care; Patient safety; Coding (social sciences); Nursing; Family medicine; Psychology; Sociology","score_opus":0.04686869312813717,"score_gpt":0.4009324925274406,"score_spread":0.35406379939930344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929153482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9396746,0.0043610246,0.0029979916,0.038646784,0.00036062874,0.000079587,0.0001562014,0.000040129995,0.013683121],"genre_scores_gemma":[0.99396837,0.0011599633,0.00058492756,0.0029147714,0.000049015915,0.00003624255,0.000029611068,0.000014753433,0.0012423821],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9828562,0.013927585,0.0003847848,0.00050601485,0.0010510556,0.0012742954],"domain_scores_gemma":[0.974206,0.018076088,0.00252469,0.00044182612,0.0019929209,0.0027586468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012934322,0.00048158638,0.00055142964,0.0008073232,0.011385397,0.004530896,0.0014692968,0.0022305418,0.0032488713],"category_scores_gemma":[0.027148155,0.0005211209,0.0005120712,0.0006584552,0.01044115,0.00515208,0.0044201533,0.004189833,0.00033641214],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043165965,0.000018493936,0.003068958,0.00009736632,0.000014660969,0.0016791981,0.9879782,0.000036142676,0.00021548966,0.0008908999,0.0017342689,0.004223006],"study_design_scores_gemma":[0.0000068938425,0.000043901182,0.0013200371,0.0001863884,0.0000135138325,0.0015869188,0.98116255,0.000066237495,0.00018102651,0.0006538235,0.0147549305,0.000023794906],"about_ca_topic_score_codex":0.017799627,"about_ca_topic_score_gemma":0.022418454,"teacher_disagreement_score":0.017799627,"about_ca_system_score_codex":0.006213379,"about_ca_system_score_gemma":0.0074667865,"threshold_uncertainty_score":0.06840408},"labels":[],"label_agreement":null},{"id":"W2933544291","doi":"10.1177/2042098619836032","title":"Abuse potential of mirogabalin in recreational polydrug users","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Daiichi Sankyo Company","keywords":"Pregabalin; Medicine; Placebo; Crossover study; Pharmacology; Drug; Randomized controlled trial; Anesthesia; Internal medicine","score_opus":0.00677971735060432,"score_gpt":0.27957617686638103,"score_spread":0.2727964595157767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933544291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969652,0.0017133541,0.00015646352,0.000042316213,0.000011151511,0.00009055991,0.00010311884,0.0000039089823,0.000913964],"genre_scores_gemma":[0.99745065,0.0013523977,0.00038355208,0.00007870626,0.000021607368,0.00007263031,0.00007051357,0.0000016790028,0.0005681329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948895,0.00032097276,0.000042927215,0.000048751994,0.000068990805,0.000029427682],"domain_scores_gemma":[0.99916685,0.00037492052,0.00027515463,0.00004752629,0.000055119686,0.000080464204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059811096,0.00024039613,0.00052638527,0.00033898428,0.00034850126,0.00034519675,0.000108365406,0.0003347496,0.0027477017],"category_scores_gemma":[0.0015526162,0.00021759898,0.0003419161,0.00030360057,0.00033618032,0.00036200637,0.00024950333,0.00045608933,0.0001585795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2317911,0.019910403,0.31512827,0.0026869301,0.0020549283,0.001311598,0.0022927837,0.00059368875,0.15318175,0.0009698406,0.00086317887,0.26921552],"study_design_scores_gemma":[0.005262569,0.24051167,0.7134946,0.0001977262,0.001492222,0.0023127398,0.0011362863,0.0016462728,0.02763106,0.0005088801,0.0057205902,0.00008542579],"about_ca_topic_score_codex":0.00060944405,"about_ca_topic_score_gemma":0.0017725013,"teacher_disagreement_score":0.0027477017,"about_ca_system_score_codex":0.00022578437,"about_ca_system_score_gemma":0.00018956444,"threshold_uncertainty_score":0.0091920495},"labels":[],"label_agreement":null},{"id":"W2964635562","doi":"10.1177/2042098619865413","title":"Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada; British Medical Association; Biocon","keywords":"Postmarketing surveillance; Medicine; Context (archaeology); Pharmacovigilance; Population; Medical prescription; Adverse effect; Business; Family medicine; Environmental health; Pharmacology","score_opus":0.07323397650846275,"score_gpt":0.38139088917345754,"score_spread":0.3081569126649948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964635562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017656176,0.9972783,0.00008736798,0.000571638,0.00011548026,0.00002030372,0.000054188138,0.000004619787,0.0016916113],"genre_scores_gemma":[0.001916981,0.99704856,0.00028836,0.00032743096,0.000075213226,0.000013359404,0.000049722057,0.0000031315508,0.0002773287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957152,0.0008283497,0.00084503583,0.00030365057,0.0019826372,0.0003251357],"domain_scores_gemma":[0.9824202,0.007983965,0.002328135,0.00023532331,0.006355527,0.00067687756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058477204,0.0010053483,0.0018329317,0.007979588,0.00126125,0.0038759983,0.002071153,0.001651496,0.004610233],"category_scores_gemma":[0.014372571,0.00048371073,0.0012925479,0.010360307,0.0020536243,0.002440923,0.0010865078,0.0017400922,0.00067675975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017645539,0.000068223744,0.0018712946,0.08098918,0.00020129424,0.00035306648,0.0008123088,0.0003182027,0.00033015822,0.007751297,0.037275128,0.8698533],"study_design_scores_gemma":[0.000020137384,0.00011983283,0.009994025,0.078921705,0.00049422256,0.0008109668,0.00058569974,0.00013698712,0.0004130022,0.0007588056,0.90766716,0.000077492776],"about_ca_topic_score_codex":0.35103598,"about_ca_topic_score_gemma":0.4471035,"teacher_disagreement_score":0.64896405,"about_ca_system_score_codex":0.015278939,"about_ca_system_score_gemma":0.042706914,"threshold_uncertainty_score":0.6979854},"labels":[],"label_agreement":null},{"id":"W2981890157","doi":"10.1177/2042098619883156","title":"Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use","year":2019,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Polypharmacy; Deprescribing; Medicine; Medical emergency; Beers Criteria; Intensive care medicine","score_opus":0.06828952103001117,"score_gpt":0.3856460790282565,"score_spread":0.3173565579982453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981890157","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016482527,0.004373056,0.000065938286,0.03945591,0.9551451,0.000018683724,0.000050710725,0.00003511899,0.0008390619],"genre_scores_gemma":[0.00011212721,0.00208592,0.000044369313,0.023947364,0.9714433,0.000018295468,0.000019226072,0.000019310122,0.002310208],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908819,0.0017892459,0.0013659394,0.0010132733,0.004373245,0.000576312],"domain_scores_gemma":[0.94375366,0.024069363,0.004954705,0.0014604689,0.018721405,0.0070404303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010936513,0.00544572,0.007610813,0.0073653236,0.0058656665,0.014147597,0.005676275,0.029366914,0.01947903],"category_scores_gemma":[0.046974167,0.0019147879,0.0053008613,0.0031997247,0.0037536924,0.006326577,0.0025305587,0.03132938,0.015057493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026027092,0.000015174391,0.00003110081,0.00019044452,0.000023561286,0.000054766537,0.000008536581,0.000011460174,0.000023634357,0.00011589322,0.9966403,0.0028590215],"study_design_scores_gemma":[0.00017333157,0.00007458291,0.0006460947,0.0017232428,0.00021678973,0.0003309964,0.00010818537,0.0002711172,0.00011531725,0.0016461764,0.9946262,0.000067991],"about_ca_topic_score_codex":0.00354093,"about_ca_topic_score_gemma":0.0122699635,"teacher_disagreement_score":0.029366914,"about_ca_system_score_codex":0.0050375448,"about_ca_system_score_gemma":0.0070137745,"threshold_uncertainty_score":0.06516385},"labels":[],"label_agreement":null},{"id":"W3095340726","doi":"10.1177/2042098620968310","title":"Prescribing cascades in persons with Alzheimer’s disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute on Aging","keywords":"Polypharmacy; Medicine; Medical prescription; Disease; Family medicine; Nursing; Pharmacology","score_opus":0.09343555958131636,"score_gpt":0.463842611985989,"score_spread":0.37040705240467264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095340726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856442,0.0003650859,0.0032604598,0.003533602,0.00011882585,0.002992842,0.00020212727,0.000058993002,0.0038239679],"genre_scores_gemma":[0.97670984,0.00078982423,0.012204419,0.0025114184,0.000079568,0.005721452,0.0001222074,0.000047640082,0.0018136443],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9515159,0.042021647,0.0014734729,0.0007425116,0.0016460682,0.0026003965],"domain_scores_gemma":[0.91370475,0.07314439,0.003678651,0.0016907221,0.004262303,0.0035192068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045821764,0.0012341288,0.0008416782,0.0012821008,0.008403301,0.0034159494,0.002278038,0.0022230092,0.004476333],"category_scores_gemma":[0.06731107,0.0008092267,0.00084080326,0.0010372081,0.0064622224,0.003375252,0.0066847056,0.0034837704,0.00043151324],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004076356,0.0014837029,0.0030389423,0.001459335,0.000016093129,0.0007911275,0.9589348,0.00017287528,0.0013254054,0.0006917563,0.0014308259,0.030247528],"study_design_scores_gemma":[0.00024131719,0.0023683074,0.0031323794,0.0012688411,0.000051124785,0.00027451792,0.9730219,0.00040337132,0.0024689971,0.00062043715,0.016098402,0.00005039942],"about_ca_topic_score_codex":0.0033110594,"about_ca_topic_score_gemma":0.0077959723,"teacher_disagreement_score":0.045821764,"about_ca_system_score_codex":0.008572183,"about_ca_system_score_gemma":0.010464755,"threshold_uncertainty_score":0.24233156},"labels":[],"label_agreement":null},{"id":"W3125106283","doi":"10.1177/2042098621989134","title":"Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Adverse effect; Systematic review; Transporter; Pharmacology; MEDLINE; Intensive care medicine; Bioinformatics; Biochemistry","score_opus":0.09842730358675036,"score_gpt":0.40746611403547806,"score_spread":0.3090388104487277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125106283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004944179,0.9977731,0.00041258073,0.0003051558,0.00010563285,0.00042714528,0.0003483905,0.000011501333,0.00012212523],"genre_scores_gemma":[0.014503013,0.9801568,0.0024494582,0.00055455347,0.00013411634,0.0017867145,0.00033659933,0.000011794087,0.00006699467],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9403155,0.025280576,0.022770612,0.0028819442,0.007998693,0.0007526512],"domain_scores_gemma":[0.77236176,0.177611,0.031620275,0.0027246296,0.014990016,0.0006923217],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.056048177,0.0029536646,0.011811668,0.024969075,0.00075733656,0.004613641,0.0027615067,0.00238175,0.0032832609],"category_scores_gemma":[0.1827331,0.0021997374,0.015437027,0.018895686,0.0014471042,0.00354739,0.002871018,0.0019456835,0.00027313773],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019261954,0.00001315515,0.00082534674,0.95056254,0.014713096,0.00004424127,0.00018979536,0.000149163,0.00009953213,0.00029325436,0.00085052266,0.032066837],"study_design_scores_gemma":[0.0002695424,0.00020850245,0.0036730587,0.8923568,0.0902944,0.0002519218,0.00023571149,0.00019426634,0.00019703618,0.0006815759,0.011577434,0.000059926224],"about_ca_topic_score_codex":0.008628958,"about_ca_topic_score_gemma":0.018692676,"teacher_disagreement_score":0.9881883,"about_ca_system_score_codex":0.007013854,"about_ca_system_score_gemma":0.015854875,"threshold_uncertainty_score":0.2964146},"labels":[],"label_agreement":null},{"id":"W3160853723","doi":"10.1177/20420986211011345","title":"Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Odds ratio; Meta-analysis; Internal medicine; Intensive care unit; Confidence interval; Intensive care medicine","score_opus":0.14488365894393107,"score_gpt":0.4613328342968165,"score_spread":0.3164491753528854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160853723","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005623119,0.99247193,0.0003998044,0.000226041,0.00009179195,0.00015933544,0.0008177475,0.000016302212,0.0001939862],"genre_scores_gemma":[0.20196897,0.79269385,0.0016128549,0.0010037884,0.00027458754,0.0008503049,0.0013300915,0.00004028609,0.0002252324],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9885084,0.0045352867,0.004083722,0.001196771,0.001237105,0.00043870183],"domain_scores_gemma":[0.96001506,0.030892884,0.0055491608,0.0009285671,0.0022654233,0.00034884387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016253939,0.0022114865,0.015561111,0.007592647,0.00061428867,0.0035572639,0.0020499611,0.002133649,0.003493755],"category_scores_gemma":[0.03964119,0.0011245083,0.039959975,0.009329239,0.000700083,0.0016679951,0.0018005532,0.0016933243,0.00027898687],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017863228,0.000027368624,0.007862441,0.39864624,0.57848066,0.00019945193,0.00012440639,0.00046649927,0.00020505601,0.00011948914,0.00064885773,0.011433202],"study_design_scores_gemma":[0.00026691935,0.00012232467,0.0060701277,0.02680875,0.96484274,0.00011356964,0.000058944323,0.0001114054,0.00007698104,0.00015331923,0.0013521926,0.000022762912],"about_ca_topic_score_codex":0.0068063326,"about_ca_topic_score_gemma":0.014133538,"teacher_disagreement_score":0.016253939,"about_ca_system_score_codex":0.002153656,"about_ca_system_score_gemma":0.0036651047,"threshold_uncertainty_score":0.08596003},"labels":[],"label_agreement":null},{"id":"W4248034719","doi":"10.1177/2042098615621264","title":"Risk of intracranial hypertension with intrauterine levonorgestrel: reply","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Levonorgestrel; Internal medicine; Family planning; Population; Environmental health","score_opus":0.01766261295001534,"score_gpt":0.27077415597657317,"score_spread":0.2531115430265578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248034719","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011187015,0.0075632213,0.00026455658,0.9548003,0.03502987,0.000008343079,0.00015007396,0.00003529312,0.0010296719],"genre_scores_gemma":[0.013087991,0.009222574,0.000561416,0.81741977,0.15686351,0.000035901263,0.00009996894,0.000029617175,0.0026792856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856865,0.0004108324,0.00035735447,0.00024456895,0.000309483,0.00010908423],"domain_scores_gemma":[0.9867582,0.0087477,0.00095704786,0.00056348817,0.0022205433,0.00075305824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002821974,0.0008125419,0.0014996477,0.0006704202,0.0010487125,0.0016703559,0.0016356807,0.023960453,0.0040392764],"category_scores_gemma":[0.018627588,0.000544987,0.0012601736,0.00075915275,0.0016619412,0.003437181,0.0010198603,0.026822666,0.0028621804],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024770616,0.000087506836,0.0052766204,0.0003383005,0.00015949247,0.007725888,0.00024061732,0.0002082979,0.0004679307,0.002314579,0.9530874,0.029845798],"study_design_scores_gemma":[0.00036000373,0.00032350054,0.010570377,0.0007885102,0.0003549863,0.019319097,0.0012582806,0.0007403229,0.0012327665,0.012384438,0.95238346,0.00028419492],"about_ca_topic_score_codex":0.0021811666,"about_ca_topic_score_gemma":0.0021405416,"teacher_disagreement_score":0.023960453,"about_ca_system_score_codex":0.0010852432,"about_ca_system_score_gemma":0.0014144422,"threshold_uncertainty_score":0.014924169},"labels":[],"label_agreement":null},{"id":"W4306669620","doi":"10.1177/20420986221129335","title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Research Foundation of Korea","keywords":"Medicine; Meta-analysis; Hazard ratio; Angiotensin Receptor Blockers; Observational study; Internal medicine; MEDLINE; Oncology; Cohort study; Relative risk; Angiotensin-converting enzyme; Publication bias; Confidence interval; Pharmacology; Blood pressure","score_opus":0.10505555536227236,"score_gpt":0.37435989132604996,"score_spread":0.2693043359637776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306669620","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067270948,0.988252,0.002176429,0.00067730574,0.00031733423,0.00017833733,0.0014296637,0.000047061032,0.00019472039],"genre_scores_gemma":[0.17010804,0.80905944,0.013943636,0.0014016088,0.0010587816,0.0011693006,0.002766067,0.00008263931,0.00041058275],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9781491,0.011348793,0.0060366895,0.0016869217,0.0024194557,0.00035896772],"domain_scores_gemma":[0.9458993,0.040931653,0.0073197572,0.0025888844,0.0029413013,0.00031903642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031864226,0.0023414397,0.012940855,0.011781556,0.0004146421,0.0035288758,0.0019577064,0.0015599739,0.0024596327],"category_scores_gemma":[0.065039515,0.0013876726,0.03392051,0.0129898265,0.0004058985,0.0019310658,0.0012932318,0.0016373314,0.00024752627],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002456683,0.0000389241,0.02509756,0.19644704,0.7305415,0.00033550686,0.00014338268,0.002053909,0.00055829546,0.00034931325,0.0025763747,0.039401542],"study_design_scores_gemma":[0.00051208737,0.00017613736,0.0139203975,0.01614879,0.9639253,0.00023611361,0.000040318377,0.0005950949,0.00017917748,0.00063938106,0.00357503,0.00005215705],"about_ca_topic_score_codex":0.0040350794,"about_ca_topic_score_gemma":0.00745992,"teacher_disagreement_score":0.031864226,"about_ca_system_score_codex":0.0017977622,"about_ca_system_score_gemma":0.002830642,"threshold_uncertainty_score":0.16851616},"labels":[],"label_agreement":null},{"id":"W4321850279","doi":"10.1177/20420986221146418","title":"Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Communications Research Centre Canada","funders":"Spark Therapeutics; Hemophilia Federation of America; HEMA Biologics; National Hemophilia Foundation; BioMarin Pharmaceutical; CSL Behring; Novo Nordisk; Sanofi; Pfizer; Roche; Bayer; Genentech; Britannia Pharmaceuticals; Grifols; Octapharma","keywords":"Medicine; Pharmacovigilance; Pharmacology; Intensive care medicine; Adverse effect; Family medicine; Pediatrics","score_opus":0.13329660432494164,"score_gpt":0.4440379314710621,"score_spread":0.31074132714612046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321850279","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015882576,0.19541368,0.013175051,0.77543634,0.007058579,0.000281462,0.00014487137,0.00049686135,0.0064049796],"genre_scores_gemma":[0.062127892,0.36487597,0.061692372,0.48988056,0.016021522,0.000866938,0.0006940784,0.00024739848,0.0035932725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.92284656,0.052493017,0.005598558,0.0025887964,0.013315553,0.0031575495],"domain_scores_gemma":[0.8167473,0.10607203,0.011069696,0.0045154477,0.041784596,0.01981096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08414061,0.0014561103,0.0031315906,0.0031260876,0.003296639,0.0129423905,0.0034559236,0.010274545,0.0050459504],"category_scores_gemma":[0.10847125,0.00089113356,0.003067516,0.0035109548,0.0039223335,0.014338257,0.011284296,0.022882877,0.0017253974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022679976,0.00018407557,0.0036709164,0.017399266,0.000608632,0.0011457171,0.008502924,0.00084166747,0.0010403559,0.04284243,0.34419435,0.5793428],"study_design_scores_gemma":[0.00022819034,0.00038723828,0.004412416,0.03898817,0.0006474948,0.002323135,0.009674939,0.0012951655,0.0009167482,0.050108105,0.8907493,0.00026920234],"about_ca_topic_score_codex":0.0061235847,"about_ca_topic_score_gemma":0.008261074,"teacher_disagreement_score":0.08414061,"about_ca_system_score_codex":0.007644814,"about_ca_system_score_gemma":0.044313952,"threshold_uncertainty_score":0.44498342},"labels":[],"label_agreement":null},{"id":"W4391294433","doi":"10.1177/20420986231224227","title":"Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Medicine; Pharmacovigilance; Odds ratio; Database; Internal medicine; Interquartile range; Adverse effect","score_opus":0.0573512260930896,"score_gpt":0.4510608166314385,"score_spread":0.39370959053834886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391294433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892944,0.0038949386,0.000262114,0.0006792615,0.00002491666,0.000067295645,0.0050534066,0.000023652772,0.000700009],"genre_scores_gemma":[0.99575305,0.0005768149,0.00016975941,0.00025718656,0.00002816498,0.000035976456,0.0030921753,0.000005790253,0.000081049766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9887262,0.0033738858,0.0031235751,0.0019480472,0.002132685,0.00069563737],"domain_scores_gemma":[0.9478301,0.008542336,0.036751095,0.0018559796,0.003957697,0.0010627913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008413475,0.00030338095,0.0005618339,0.00395086,0.00044536887,0.0017287921,0.00080289075,0.00089006685,0.0013082618],"category_scores_gemma":[0.027058242,0.0003748201,0.001104837,0.006323005,0.000413471,0.0016987418,0.0013591608,0.0009062401,0.0002928768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001800487,0.000029388582,0.9972114,0.00005708051,0.00011765515,0.00011778965,0.00012329636,0.00004460587,0.000053702475,0.00003205128,0.0003957288,0.0016372451],"study_design_scores_gemma":[0.000020047348,0.000107212894,0.9969754,0.0000683518,0.000158417,0.00069249386,0.00046683103,0.00054484914,0.00007468801,0.000023275876,0.000856745,0.000011598576],"about_ca_topic_score_codex":0.015799472,"about_ca_topic_score_gemma":0.009520314,"teacher_disagreement_score":0.015799472,"about_ca_system_score_codex":0.0020619044,"about_ca_system_score_gemma":0.0015400853,"threshold_uncertainty_score":0.044495285},"labels":[],"label_agreement":null},{"id":"W4391546075","doi":"10.1177/20420986241228119","title":"Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harmonization; Pharmacovigilance; Medicine; Guideline; Drug reaction; Latin Americans; Authorization; Business; Regulatory authority; Environmental health; Accounting; Political science; Pharmacology; Adverse effect; Public administration; Drug; Computer security; Computer science","score_opus":0.18672207394740206,"score_gpt":0.5018522761571692,"score_spread":0.3151302022097672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391546075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013884111,0.7588277,0.074218355,0.067966074,0.0054637566,0.0043237885,0.0020211746,0.0009733495,0.07232176],"genre_scores_gemma":[0.13712351,0.69271594,0.11023464,0.030301148,0.004631571,0.005969164,0.0063621337,0.00059958507,0.01206231],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.89083636,0.03362687,0.02643795,0.0073408145,0.039114427,0.0026436397],"domain_scores_gemma":[0.84834546,0.067039706,0.018323893,0.008981761,0.055206534,0.0021027077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.109025285,0.00094243855,0.0017457322,0.008811371,0.002000422,0.008068892,0.007053011,0.004277646,0.0025905098],"category_scores_gemma":[0.11582103,0.0010533725,0.0019830114,0.008242477,0.0049946317,0.0055526444,0.0042715594,0.004806777,0.0013786876],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014901049,0.0002197979,0.0056796535,0.017075231,0.00017920129,0.0007024685,0.0034371098,0.0015462865,0.0021449174,0.066943325,0.05140433,0.8505186],"study_design_scores_gemma":[0.000057741418,0.0002122215,0.010442571,0.026408244,0.00025860936,0.0016110669,0.0013827338,0.0010013935,0.0023138612,0.010464594,0.9457098,0.00013721047],"about_ca_topic_score_codex":0.00805991,"about_ca_topic_score_gemma":0.0042575435,"teacher_disagreement_score":0.109025285,"about_ca_system_score_codex":0.0067672892,"about_ca_system_score_gemma":0.024359148,"threshold_uncertainty_score":0.5765877},"labels":[],"label_agreement":null},{"id":"W4405771294","doi":"10.1177/20420986241309882","title":"Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Institut National de Santé Publique du Québec","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada","keywords":"Polypharmacy; Medicine; Cohort; Population; Association (psychology); Pharmacoepidemiology; Gerontology; Family medicine; Environmental health; Internal medicine; Pharmacology; Medical prescription","score_opus":0.011895100423129832,"score_gpt":0.34206337905623807,"score_spread":0.3301682786331082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405771294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870647,0.00096243346,0.00024436513,0.0003540973,0.00001536216,0.00007354447,0.009598619,0.000017477625,0.0016693075],"genre_scores_gemma":[0.9973079,0.00028822903,0.00016239531,0.00010415805,0.0000063525476,0.000022349968,0.0015484014,0.0000033166448,0.0005569683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993587,0.000051820578,0.000048117818,0.00013684202,0.00024175794,0.0001627988],"domain_scores_gemma":[0.99839145,0.00007420276,0.00042407334,0.000062203886,0.00071232446,0.0003357666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059148984,0.00033267593,0.00040816606,0.0010932116,0.0014061475,0.000964764,0.00096583273,0.00050036045,0.0016514616],"category_scores_gemma":[0.0015149544,0.000264586,0.00051105156,0.0026104169,0.00044858427,0.00044515159,0.00051331386,0.0006561245,0.00018375531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002301365,0.000012639407,0.99839276,0.000013470897,0.000039902825,0.000025158886,0.00010630297,0.00004291212,0.00008124634,0.00001817972,0.00047022538,0.000774169],"study_design_scores_gemma":[0.0000033397882,0.000012438997,0.9992906,0.000012459489,0.000017082055,0.000028767077,0.00017042816,0.00018037403,0.000014232494,0.000006825902,0.00025983472,0.0000036107829],"about_ca_topic_score_codex":0.9878869,"about_ca_topic_score_gemma":0.99017835,"teacher_disagreement_score":0.012474564,"about_ca_system_score_codex":0.012474564,"about_ca_system_score_gemma":0.010603479,"threshold_uncertainty_score":0.09050971},"labels":[],"label_agreement":null},{"id":"W4411452877","doi":"10.1177/20420986251347360","title":"Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Misericordia Community Hospital; Alberta Hospital Edmonton; Health Sciences Centre; Sunnybrook Health Science Centre; University of British Columbia; Centre for Addiction and Mental Health; Queen's University; University of Toronto; Providence Health Care; Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Depression (economics); Observational study; Real world evidence; Cohort; Cohort study; Intensive care medicine; Psychiatry; Emergency medicine; Internal medicine","score_opus":0.06788609557223399,"score_gpt":0.4571484546264376,"score_spread":0.3892623590542036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411452877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995609,0.00008635582,0.0000677942,0.000010938998,0.0000040183954,0.000043159984,0.00012219072,0.0000013639215,0.00010336858],"genre_scores_gemma":[0.9991998,0.00006823222,0.00012075912,0.000035045578,0.000011508632,0.000056460914,0.00040827473,0.0000014417304,0.0000984739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998835,0.0004211599,0.00017448004,0.0002345728,0.0002066632,0.00012809024],"domain_scores_gemma":[0.99682117,0.0005104076,0.0016480151,0.00035442977,0.0002961202,0.00036978227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014429374,0.00029987612,0.00063656905,0.0007584401,0.0005236077,0.0005981384,0.00042603383,0.0005348542,0.0011204787],"category_scores_gemma":[0.0030313607,0.0003133218,0.0009507018,0.0007477176,0.00033315647,0.00040022953,0.0006855524,0.0006039226,0.0002721014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069751695,0.00032630088,0.99710435,0.000029506122,0.0001409754,0.000101937905,0.00015258873,0.000017750172,0.0003519532,0.000010189053,0.00008116394,0.0009857292],"study_design_scores_gemma":[0.00009419196,0.0011881934,0.99774075,0.000009365154,0.000068488414,0.0002564259,0.00024536025,0.00017431233,0.00006196358,0.0000071168843,0.00014858226,0.0000052806545],"about_ca_topic_score_codex":0.0025811791,"about_ca_topic_score_gemma":0.0033272852,"teacher_disagreement_score":0.0025811791,"about_ca_system_score_codex":0.0004144425,"about_ca_system_score_gemma":0.00045525774,"threshold_uncertainty_score":0.0076310635},"labels":[],"label_agreement":null},{"id":"W4411467706","doi":"10.1177/20420986251347354","title":"Beyond pain relief: the thrombosis threat of celecoxib","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Celecoxib; Thrombosis; Intensive care medicine; Anesthesia; Pharmacology; Internal medicine","score_opus":0.0064727027006660455,"score_gpt":0.28880543467430386,"score_spread":0.28233273197363784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411467706","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14808132,0.47788864,0.012999616,0.30351606,0.00543172,0.00023060736,0.0008394051,0.00010389966,0.050908767],"genre_scores_gemma":[0.79904705,0.13828285,0.0042491006,0.03833497,0.014929194,0.00013749766,0.00030777472,0.000026397052,0.004685181],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936579,0.0039321124,0.00043747298,0.00025763566,0.0014565461,0.0002584305],"domain_scores_gemma":[0.9787729,0.013426934,0.004527066,0.0005387358,0.0020803194,0.00065416505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071529853,0.00035822022,0.0007907697,0.0008377187,0.00064516976,0.0022942198,0.0004958823,0.001494145,0.007373995],"category_scores_gemma":[0.032071687,0.00012399163,0.000931348,0.0010260517,0.0016563217,0.0015072785,0.0008925965,0.0022474527,0.0005959149],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004221571,0.0003479853,0.086654186,0.0072894953,0.0010875718,0.003799557,0.0018945541,0.0012864061,0.0037161373,0.037393708,0.050422147,0.8018867],"study_design_scores_gemma":[0.0020416277,0.012865732,0.27584794,0.016274845,0.0035159397,0.043583993,0.0076905596,0.006283431,0.0069666984,0.16051973,0.46406275,0.0003467873],"about_ca_topic_score_codex":0.0013524578,"about_ca_topic_score_gemma":0.0012555216,"teacher_disagreement_score":0.007373995,"about_ca_system_score_codex":0.0010977675,"about_ca_system_score_gemma":0.001647918,"threshold_uncertainty_score":0.0378291},"labels":[],"label_agreement":null},{"id":"W4417348029","doi":"10.1177/20420986251405091","title":"Evaluating seizures associated with novel antineoplastic agents during breast cancer treatment using the Food and Drug Administration Adverse Event Reporting System and Canada Vigilance Adverse Reaction Online Database","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"China Primary Health Care Foundation","keywords":"Pharmacovigilance; Adverse Event Reporting System; Vigilance (psychology); Food and drug administration; Adverse effect; Adverse drug event; Breast cancer; Drug reaction; Adverse drug reaction","score_opus":0.08656220519098266,"score_gpt":0.44564625855438,"score_spread":0.3590840533633973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417348029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85466963,0.0056006806,0.004004982,0.0006910732,0.000028368539,0.0011507928,0.12708957,0.00024450905,0.006520397],"genre_scores_gemma":[0.9521246,0.0014152115,0.0035055308,0.00023148707,0.000019938436,0.0003131091,0.04192681,0.00001739776,0.00044578064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99026006,0.0014489501,0.0023093116,0.0013371772,0.004221069,0.00042351842],"domain_scores_gemma":[0.9551272,0.007250015,0.02402976,0.0016021299,0.011078177,0.0009128447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072100754,0.00032303217,0.0005561469,0.0057547083,0.00048411224,0.0011829862,0.00076285744,0.0003074208,0.0010003538],"category_scores_gemma":[0.025335925,0.00015610228,0.0008509106,0.008300562,0.0003388213,0.0004896825,0.00084998395,0.0004249559,0.00016579736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038543716,0.00003129495,0.9758419,0.00051949976,0.0004686788,0.00011549989,0.00019096526,0.00065038557,0.00043854935,0.00018518239,0.0026760972,0.018496582],"study_design_scores_gemma":[0.000039508013,0.00010623266,0.99146277,0.0001077465,0.00029203747,0.00026072704,0.0001859175,0.0019715098,0.00080342405,0.00006747274,0.004675702,0.000026955719],"about_ca_topic_score_codex":0.51369727,"about_ca_topic_score_gemma":0.58892405,"teacher_disagreement_score":0.48630273,"about_ca_system_score_codex":0.007435918,"about_ca_system_score_gemma":0.011603201,"threshold_uncertainty_score":0.97833335},"labels":[],"label_agreement":null},{"id":"W7117130945","doi":"10.1177/20420986251395925","title":"Complex chronic adverse events following immunization: a systemic critique and reform proposal for vaccine pharmacovigilance","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Pharmacovigilance; Adverse effect; Vaccination; Public health; Position paper; Orthostatic vital signs; Pandemic","score_opus":0.0357632173899468,"score_gpt":0.4485094486427596,"score_spread":0.4127462312528128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117130945","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008028791,0.006271207,0.012710111,0.97361666,0.003485034,0.000056844405,0.000025037181,0.00005764153,0.0029746017],"genre_scores_gemma":[0.14956583,0.013342201,0.051268984,0.7470898,0.03464698,0.00075440505,0.000082791,0.00021592247,0.003033138],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8101685,0.120448574,0.01933402,0.013983018,0.032808058,0.0032578604],"domain_scores_gemma":[0.5817866,0.33637685,0.010520104,0.018289136,0.047451142,0.0055761877],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2633604,0.0013072721,0.0030195236,0.0060405866,0.00910727,0.027223857,0.008114164,0.033907585,0.0018273628],"category_scores_gemma":[0.28390035,0.001160826,0.0041191163,0.00319231,0.09447579,0.028509593,0.018960373,0.061024044,0.00096152286],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006169128,0.00004754484,0.0011760427,0.00082849,0.00008928909,0.00041130523,0.013724702,0.00069282507,0.00022940246,0.89227563,0.04747837,0.0429847],"study_design_scores_gemma":[0.00013435828,0.0001604368,0.001014699,0.0042390795,0.00019339439,0.0010668002,0.0061857086,0.002845259,0.00044314077,0.6879716,0.29554656,0.00019897908],"about_ca_topic_score_codex":0.010011982,"about_ca_topic_score_gemma":0.0065550045,"teacher_disagreement_score":0.2633604,"about_ca_system_score_codex":0.023129756,"about_ca_system_score_gemma":0.05873357,"threshold_uncertainty_score":0.90840775},"labels":[],"label_agreement":null}]}